58 results
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
30 Apr 24
Report of Foreign Private Issuer
4:01pm
the consummation of the acquisition of The Social Proxy Ltd., as detailed in the Company’s 6-k dated March 21, 2024.
About XTL Biopharmaceuticals Ltd. (XTL)
XTL
6-K/A
EX-99.1
XTLB
X.T.L. Biopharmaceuticals Ltd.
21 Mar 24
Extraordinary General Meeting of Shareholders
5:13pm
Party, to be funded conditional upon the consummation of the acquisition of The Social Proxy Ltd., as detailed in the Company’s 6-k dated March 20, 2024 … conditional upon the consummation of the acquisition of The Social Proxy Ltd., as detailed in the Company’s Form 6-K dated March 20, 2024.
We currently
6-K/A
EX-99.2
XTLB
X.T.L. Biopharmaceuticals Ltd.
21 Mar 24
Extraordinary General Meeting of Shareholders
5:13pm
Million from certain investors, including an Interested Party, to be funded conditional upon the consummation of the acquisition of The Social Proxy Ltd
6-K
EX-99.2
XTLB
X.T.L. Biopharmaceuticals Ltd.
21 Mar 24
Extraordinary General Meeting of Shareholders
4:31pm
Million from certain investors, including an Interested Party, to be funded conditional upon the consummation of the acquisition of The Social Proxy Ltd
6-K
EX-99.1
8br3py8lag0i 0txd
21 Mar 24
Extraordinary General Meeting of Shareholders
4:31pm
20-F/A
220kt5rdgsayh
19 May 21
Annual report (foreign) (amended)
11:30am
6-K
EX-99.1
r6t w1m89
25 Nov 20
Annual General Meeting of Shareholders
10:40am
6-K
EX-99.1
zn0kdi
26 May 20
Extraordinary General Meeting of Shareholders
9:45am
6-K/A
EX-99.1
6ewfr0y8z15rd1q
13 Jan 20
Annual General Meeting of Shareholders
6:38am
6-K
EX-99.1
f1ys5r 82a68e
18 Dec 19
Annual General Meeting of Shareholders
2:38pm
20-F/A
qt4wu0
3 Apr 17
Annual report (foreign) (amended)
12:00am
F-1
EX-10.11
ej6ox7v5i79akmq z1
31 Dec 15
Registration statement (foreign)
12:00am